CONDENSED CONSOLIDATED STATEMENT OF EQUITY (Unaudited) - USD ($) $ in Thousands	Total	At-The-Market Offering	Private Placement	Controlled Equity Offering	Ideanomics Shareholders’ equity	Ideanomics Shareholders’ equity At-The-Market Offering	Ideanomics Shareholders’ equity Private Placement	Ideanomics Shareholders’ equity Controlled Equity Offering	Common Stock	Common Stock At-The-Market Offering	Common Stock Private Placement	Common Stock Controlled Equity Offering	Additional Paid-in  Capital	Additional Paid-in  Capital At-The-Market Offering	Additional Paid-in  Capital Private Placement	Additional Paid-in  Capital Controlled Equity Offering	Treasury Stock	Accumulated Deficit	Accumulated Other Comprehensive Loss	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020									344,861,295
Beginning balance at Dec. 31, 2020	$ 187,434				$ 183,695				$ 345				$ 531,866					$ (349,747)	$ 1,231	$ 3,739	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,040				2,040								2,040
Contingent shares	7,658				7,658								7,658
Common stock issuance for acquisition (in shares)									10,181,299
Common stock issuance for acquisition	32,377				32,377				$ 10				32,367
Common stock issuance (in shares)									17,615,534
Common stock issuance	53,407				53,407				$ 18				53,389
Common stock issuance for professional fee (in shares)									440,909
Common stock issuance for professional fee	1,162				1,162								1,162
Common stock issued under employee stock incentive (in shares)									475,000
Common stock issued under employee stock incentive plan	251				251								251
Common stock issuance for convertible note (in shares)									45,895,763
Common stock issuance for convertible note	140,126				140,126				$ 46				140,080
Net income (loss)	(6,719)				(6,483)													(6,483)		(236)	[1]
Foreign currency translation adjustments	(693)				(380)														(380)	(313)	[1]
Ending balance (in shares) at Mar. 31, 2021									419,469,800
Ending balance at Mar. 31, 2021	417,043				413,853				$ 419				768,813					(356,230)	851	3,190	[1]
Beginning balance (in shares) at Dec. 31, 2020									344,861,295
Beginning balance at Dec. 31, 2020	187,434				183,695				$ 345				531,866					(349,747)	1,231	3,739	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance (in shares)			10,000,000
Common stock issuance			$ 27,300
Ending balance (in shares) at Jun. 30, 2021									466,354,487
Ending balance at Jun. 30, 2021	543,198				540,282				$ 466				901,943					(362,925)	798	2,916	[1]
Beginning balance (in shares) at Dec. 31, 2020									344,861,295
Beginning balance at Dec. 31, 2020	187,434				183,695				$ 345				531,866					(349,747)	1,231	3,739	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Changes in fair value of available-for-sale securities	(16)
Foreign currency translation adjustments	(1,683)
Ending balance (in shares) at Sep. 30, 2021									481,901,523
Ending balance at Sep. 30, 2021	527,727				525,199				$ 483				939,516					(414,736)	(64)	2,528	[1]
Beginning balance (in shares) at Dec. 31, 2020									344,861,295
Beginning balance at Dec. 31, 2020	187,434				183,695				$ 345				531,866					(349,747)	1,231	3,739	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance for acquisition (in shares)									11,300,000
Ending balance (in shares) at Dec. 31, 2021									497,272,525
Ending balance at Dec. 31, 2021	365,368				363,027				$ 497				968,066				$ 0	(605,758)	222	2,341
Beginning balance (in shares) at Mar. 31, 2021									419,469,800
Beginning balance at Mar. 31, 2021	417,043				413,853				$ 419				768,813					(356,230)	851	3,190	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,007				2,007								2,007
Common stock issuance for acquisition (in shares)									6,733,497
Common stock issuance for acquisition	21,127				21,127				$ 7				21,120
Common stock issuance (in shares)										25,301,190	10,000,000
Common stock issuance		$ 74,347	$ 27,300			$ 74,347	$ 27,300			$ 25	$ 10			$ 74,322	$ 27,290
Common stock issuance for professional fee (in shares)									260,000
Common stock issuance for professional fee	656				656								656
Common stock issued under employee stock incentive (in shares)									4,590,000
Common stock issued under employee stock incentive plan	7,740				7,740				$ 5				7,735
Changes in fair value of available-for-sale securities	(20)				(20)														(20)
Net income (loss)	(6,962)				(6,695)													(6,695)		(267)	[1]
Foreign currency translation adjustments	(40)				(33)														(33)	(7)	[1]
Ending balance (in shares) at Jun. 30, 2021									466,354,487
Ending balance at Jun. 30, 2021	543,198				540,282				$ 466				901,943					(362,925)	798	2,916	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	15,187				15,187								15,187
Contingent shares	(6,138)				(6,138)								(6,138)
Common stock issuance for acquisition (in shares)									2,011,617
Common stock issuance for acquisition	6,304				6,304				$ 2				6,302
Common stock issuance (in shares)										7,495,997		1,988,401
Common stock issuance		$ 17,744		$ 4,203		$ 17,744		$ 4,203		$ 7		$ 2		$ 17,737		$ 4,201
Common stock issued under employee stock incentive (in shares)									4,051,021
Common stock issued under employee stock incentive plan	299				299				$ 6				293
Changes in fair value of available-for-sale securities	4				4														4
The effects of changes in exchange rate of RNCI	(9)				(9)								(9)
Net income (loss)	(52,114)				(51,811)													(51,811)		(303)	[1]
Foreign currency translation adjustments	(951)				(866)														(866)	(85)	[1]
Ending balance (in shares) at Sep. 30, 2021									481,901,523
Ending balance at Sep. 30, 2021	527,727				525,199				$ 483				939,516					(414,736)	(64)	2,528	[1]
Beginning balance (in shares) at Dec. 31, 2021									497,272,525
Beginning balance at Dec. 31, 2021	365,368				363,027				$ 497				968,066				0	(605,758)	222	2,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,355				2,355								2,355
Common stock issuance for professional fee (in shares)									350,000
Common stock issuance for professional fee	435				435				$ 1				434
Common stock issued under employee stock incentive (in shares)									125,000
Common stock issued under employee stock incentive plan	66				66								66
Tax withholding paid for net share settlement of equity awards	(83)				(83)								(83)
Deconsolidation of subsidiary	(236)																			(236)
Acquisition of Energica	24,778																			24,778
Net income (loss)	(29,092)				(28,512)													(28,512)		(580)
Foreign currency translation adjustments	1,209				925														925	284
Ending balance (in shares) at Mar. 31, 2022									497,747,525
Ending balance at Mar. 31, 2022	364,800				338,213				$ 498				970,838				0	(634,270)	1,147	26,587
Beginning balance (in shares) at Dec. 31, 2021									497,272,525
Beginning balance at Dec. 31, 2021	$ 365,368				363,027				$ 497				968,066				0	(605,758)	222	2,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issuance for acquisition (in shares)									0
Common stock issuance for professional fee (in shares)	1,100,000
Changes in fair value of available-for-sale securities	$ 0
Foreign currency translation adjustments	(15,930)
Ending balance (in shares) at Sep. 30, 2022									517,134,223
Ending balance at Sep. 30, 2022	282,636				262,775				$ 517				980,232				4,639	(709,451)	(13,162)	19,861
Beginning balance (in shares) at Mar. 31, 2022									497,747,525
Beginning balance at Mar. 31, 2022	364,800				338,213				$ 498				970,838				0	(634,270)	1,147	26,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,863				2,863								2,863
Acquisition of Energica	49																			49
Net income (loss)	(39,273)				(37,767)													(37,767)		(1,506)
Foreign currency translation adjustments	(9,012)				(6,838)														(6,838)	(2,174)
Ending balance (in shares) at Jun. 30, 2022									497,747,525
Ending balance at Jun. 30, 2022	319,427				296,471				$ 498				973,701				0	(672,037)	(5,691)	22,956
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation	2,234				2,234								2,234
Common stock issuance for acquisition (in shares)									(6,627,565)
Common stock issuance for acquisition	$ (1)				(1)				$ (7)				(4,633)				4,639
Common stock issuance for professional fee (in shares)	1,100,000								1,059,006
Common stock issuance for professional fee	$ 690				690				$ 1				689
Common stock issuance for convertible note (in shares)									23,455,257
Common stock issuance for convertible note	7,523				7,523				$ 23				7,500
Investments from noncontroller shareholders	264																			264
Option repurchase	(11)				(11)								(11)
Changes in fair value of available-for-sale securities	0
Equity Adjustment from Foreign Currency Translation	754				(1,264)														(1,264)
SEPA Inducement shares (in shares)									1,500,000
SEPA Inducement shares	754				754				$ 2				752
Net income (loss)	(38,853)				(37,414)													(37,414)		(1,439)
Foreign currency translation adjustments	(8,127)				(6,207)														(6,207)	(1,920)
Ending balance (in shares) at Sep. 30, 2022									517,134,223
Ending balance at Sep. 30, 2022	$ 282,636				$ 262,775				$ 517				$ 980,232				$ 4,639	$ (709,451)	$ (13,162)	$ 19,861

[1] Excludes accretion of dividend for redeemable non-controlling interest.